Chemical Industry News, Data & Insights

Croda Partners with Amino to Enhance Biopharma Capabilities

Key highlights
  • Croda partners with Amino to enhance global availability of high-purity amino acids.
  • The collaboration focuses on pharmaceutical formulation and biomanufacturing.
  • BioXPro™ high-purity histidine and arginine amino acids launch in January 2026.

Partnership Announcement

Croda International Plc has announced a strategic supply partnership with Amino GmbH to enhance the global availability of high-purity amino acids for pharmaceutical formulation and biomanufacturing.

Amino Acids in Pharmaceuticals

Amino acids, essential for proteins, are used in pharmaceuticals as excipients for biologic drugs and as ingredients in manufacturing biologicals like monoclonal antibodies.

Launch of BioXPro™ Products

The partnership will see the launch of BioXPro™ high-purity histidine and arginine amino acids in January 2026, offering purity, consistency, and batch-to-batch reproducibility.

Strategic Goals

This collaboration aligns with Croda's strategy to support customers in the evolving biopharma landscape, leveraging Amino's expertise in high-purity amino acid production.